Cargando…
Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice
Berberine (Ber), an isoquinoline derivative alkaloid and active ingredient of Coptis, has been demonstrated to possess antidiabetic activities. However its low oral bioavailability restricts its clinical application. In this report, Ber nanosuspension (Ber-NS) composed of Ber and D-α-tocopheryl poly...
Autores principales: | Wang, Zhiping, Wu, Junbiao, Zhou, Qun, Wang, Yifei, Chen, Tongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381853/ https://www.ncbi.nlm.nih.gov/pubmed/25866534 http://dx.doi.org/10.1155/2015/239749 |
Ejemplares similares
-
Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice
por: Ma, Xiaomeng, et al.
Publicado: (2010) -
Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins
por: Zhang, Haoyue, et al.
Publicado: (2018) -
Knockout of the TauT Gene Predisposes C57BL/6 Mice to Streptozotocin-Induced Diabetic Nephropathy
por: Han, Xiaobin, et al.
Publicado: (2015) -
Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice
por: Blauwkamp, Marsha N, et al.
Publicado: (2008) -
Anti-Obesity and Hypoglycemic Effects of Poncirus trifoliata L. Extracts in High-Fat Diet C57BL/6 Mice
por: Jia, Sheng, et al.
Publicado: (2016)